Market update, August 21 – Business Insider

Wikimedia CommonsWe just witnessed the worst week for the US stock market in four years. The blue-chip Dow fell more than 500 points Friday and entered correction territory on an intra-day basis — defined as a 10% drop from recent highs. Major stock markets across Europe and Asia also closed sharply lower.First, the scoreboard:Dow: 16,459.75, -530.94, (-3.12%)
S&P 500: 1,970.89, -64.84, (-3.19%)
Nasdaq: 4,706.04, -171.45, (-3.52%)
And […]

Tracking the Footprints of Supply and Demand in the Stock Market

TraderFeed: Tracking the Footprints of Supply and Demand in the Stock Market

Tracking the Footprints of Supply and Demand in the Stock MarketIn some ideal, dispassionate world all participants in financial markets would behave like my friend NRK and only buy at bid prices and sell at offers. It’s a great way to do well in auction markets, and there are […]

Why short-selling ban won't help Chinese stock market – Business …

REUTERS/Jason ReedChina is trying hard to hold up its stock market.The first sign of a full-blown crisis is when the government tries to ban short-selling, and China is no exception.Short-sellers borrow stocks and immediately sell them off, reasoning they can buy them back at a lower price in the future and pocket the difference.But their negative bets put downward pressure […]

Come For The Fun, But Stay For the Performance

Stock indexes fell again, capping a week in which the Dow Jones Industrial Average posted its steepest decline since December, driven by large share-price swings at widely followed companies issuing quarterly earnings reports.Shares of biotechnology companies led Friday’s decline, after Biogen plunged 22% on a soft sales outlook. The biotech pullback countered a 9.8% gain in, the latest stock-price […]

TraderFeed: Are We Significantly Oversold In The Stock Market?

Above is a useful short-term measure of whether we are trading in an “overbought” versus “oversold” mode in the U.S. stock market. The blue line is the cash SPX; the red line is a five-day moving average of the following:(5-day new highs minus 5-day new lows) + (20-day new highs minus 20-day new lows) + (100-day new highs minus 100-day […]

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data …

Eleven Biotherapeutics (EBIO – Snapshot Report) suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird (BLUE – Snapshot Report), Agios (AGIO – Snapshot Report) and Acceleron (XLRN – Snapshot Report) all got encouraging news on the regulatory front. Achillion (ACHN – Snapshot Report) struck a collaboration agreement with Johnson & Johnson […]

STTG Market Recap Mar 25, 2015 – Stock Trading To Go

A very interesting day in the markets as the S&P 500 fell 1.46% and the NASDAQ 2.37%.  Biotechs were crushed today – we’ve been saying the higher they go the more risk they get as they have been on a mostly interrupted run for 4+ years.   That said you just never know when they will correct and even if it’s […]


KITE Flying High! KITE, JUNO, BLCM, BLUEShares of Kite Pharma, Inc. (KITE) popped nearly +16% today, afterthe company announced acquisition of a privately held Netherlands-based biotechnology company, T-Cell Factory B.V. This may not have been the only reason. Juno Therapeutics (JUNO) said today that it expects to have 10 product candidates in clinical development directed at six different cancer-associated antigens. […]

Spot the ‘Hidden’ Bear Market In the Dow

CNBC: March 17, 2015A Hidden Bear Market In the Dow Threatens All Stocks“A third of the members of the blue chip barometer have hit new 52-week lows this year. By no coincidence, the Dow briefly turned negative for 2015 Tuesday.”% of Dow stocks above 200 day moving averageAnd LumberZH: March 17th, 2015: Housing Starts at 18 Month Lows. Biggest drop […]

Pullback Deepens

Stocks moved lower on Tuesday, extending the pullback from recent highs. Trading picked up as money appears to be shifting out of index names. Leading stocks generally dropped, but not the usual 2x pace of the market. In fact, there were plenty of leaders that moved higher or held strong. Biotechs were flashing buy signals (OTIC, ZFGN, etc.) or were […]